China Pharma Holdings Stock Price and Value Analysis

China Pharma Holdings (NYSE American:CPHI) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold China Pharma Holdings to reach your target.

Target type

CPHI Free Cash Flow Trend

Free Cash Flow trendline for CPHI
Free Cash Flow trendline for China Pharma Holdings

Hmm, we can't give any reliable projection for China Pharma Holdings's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
None.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is not making money.
  • This company pays no dividend.

Inside the CPHI Numbers

CPHI Price
(China Pharma Holdings stock price per share)
$0.52
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Drug Manufacturers - General stocks
[?] Cash Yield 15.03%
[?] Free Cash Flow Jitter 74%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 89,473 shares shorted. With 3,300,648 shares available for purchase and an average trading volume over the past 10 trading days of 75,470, it would take at least 1.2 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Price Versus Our Estimated Value

Positive free cash flow appears in 10 of the 16 fiscal years we hold for China Pharma Holdings from its current SEC filer.

Free cash flow is volatile from year to year, with a variability measure of 74%.

We do not estimate a fair value for China Pharma Holdings while its free cash flow growth is not positive, so there is no value comparison here.

No dividend yield is recorded for China Pharma Holdings in our data.

Our value investing guide explains how to test these numbers against the filings themselves.

Compared With Its Sector and Industry

Its trailing P/E ratio is 100% below the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 100% below the average for stocks in the Drug Manufacturers - General industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1106644.

Each figure on this page comes from that filer.

Risks to This Analysis

  • Free cash flow was negative in 6 of the 16 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • We have no value estimate for this stock, so no price comparison is made.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in CPHI

Does China Pharma Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: CPHI

This example shows how we apply the Trendshare checklist to CPHI: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 0.52
    • Market cap: $22M
    • EPS: -0.42
  2. Step 2 — Valuation checks

    • P/E: —
    • FCF yield: 15.0%
    • Date checked: Nov 14, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.